Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shigella Challenge/Rechallenge Study
NCT04992520Phase 1Completed
- Sponsor
- PATH
- Start
- Apr 2022
- Primary completion
- Aug 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial in shigellosis (6 arms), sponsored by PATH. Primary endpoint: Percentage of Participants With Shigellosis Following Shigella Challenge at 8 days. Started Apr 2022; status: completed.
02
Conditions
shigellosis
Beyond the preview
Go deeper on NCT04992520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04992520.